Effects of transendocardial CD34+ cell transplantation on diastolic parameters in patients with nonischemic dilated cardiomyopathy

Stem Cells Translational Medicine

Volumn 6, Issue 6, 2017, Pages 1515-1521

  Bervar, Mojca ^a   Kozelj, Mirta ^a   Poglajen, Gregor ^a   Sever, Matjaz ^a   Zemljic, Gregor ^a   Frljak, Sabina ^a   Cukjati, Marko ^b   Cernelc, Peter ^a   Haddad, François ^c   Vrtovec, Bojan ^a,c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b National Blood Transfusion Institute   (Slovenia)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diastolic dysfunction cardiomyopathy; Heart failure; Stem cell

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CD34 ANTIBODY; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APHERESIS; ARTICLE; BLOOD FLOW VELOCITY; CARDIAC MAPPING SYSTEM; CARDIOVASCULAR PARAMETERS; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; MALE; MIDDLE AGED; MYOCARDIAL HIBERNATION; NONISCHEMIC CARDIOMYOPATHY; OPEN STUDY; SIX MINUTE WALK TEST; STEM CELL MOBILIZATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DRUG EFFECT; GENETICS; METABOLISM; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROCEDURES;

ADULT; ANTIGENS, CD34; CARDIOMYOPATHY, DILATED; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERIPHERAL BLOOD STEM CELLS;

EID: 85020059848     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.1002/sctm.16-0331     Document Type: Article

References (25)

1. Badano LP, Albanese MC, De Biaggio P et al. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction. J Am Soc Echocardiogr 2004;17:253–261.
2. Hirata K, Hyodo E, Hozumi T et al. Usefulness of a combination of systolic function by left ventricular ejection fraction and diastolic function by E/E’ to predict prognosis in patients with heart failure. Am J Cardiol 2009; 103:1275–1279.
3. Pawlak A, Gil RJ, Nasierowska-Guttmejer AM et al. Changes in desmin expression in patients with cardiac diastolic dysfunction and preserved or reduced ejection fraction. Adv Med Sci 2015;60:148–155.
4. Abbate A, Arena R, Abouzaki N et al. Heart failure with preserved ejection fraction: Refocusing on diastole. Int J Cardiol 2015;179: 430–440.
5. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013;62:263–271.
6. Fukuta H, Little WC. Contribution of systolic and diastolic abnormalities to heart failure with a normal and a reduced ejection fraction. Prog Cardiovasc Dis 2007;49:229–240.
7. Roura S, Bayes-Genis A. Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat Rev Cardiol 2009;6:590–598.
8. + cell transplantation in patients with nonischemic dilated cardiomyopathy. Circulation 2013;128:S42–S49.
9. + stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res 2013;112:165–173.
10. Majka M, Janowska-Wieczorek A, Ratajczak J et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(1) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001;97:3075–3085.
11. + cells is associated with improved myocardial perfusion in patients with non-ischemic dilated cardiomyopathy. J Card Fail 2015;21: 145–152.
12. McMurray JJ, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803–869.
13. Gyöngyösi M, Dib N. Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease. Nat Rev Cardiol 2011; 8:393–404.
14. Hutchinson MD, Gerstenfeld EP, Desjardins B et al. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2011;4:49–55.
15. Campos B, Jauregui ME, Park KM et al. New unipolar electrogram criteria to identify irreversibility of nonischemic left ventricular cardiomyopathy. J Am Coll Cardiol 2012;60: 2194–2204.
16. Lang RM, Bierig M, Devereux RB et al. Chamber quantification writing group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–1463.
17. Olsson LG, Swedberg K, Clark AL et al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: A systematic review. Eur Heart J 2005;26:778–793.
18. Diederichsen AC, Møller JE, Thayssen P et al. Changes in left ventricular filling patterns after repeated injection of autologous bone marrow cells in heart failure patients. Scand Cardiovasc J 2010;44:139–145.
19. Fukuta H, Little WC. Contribution of systolic and diastolic abnormalities to heart failure with a normal and a reduced ejection fraction. Prog Cardiovasc Dis 2007;49:229–240.
20. Brucks S, Little WC, Chao T et al. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol 2005;95:603–606.
21. Collins J, Sommerville C, Magrath P et al. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy. Circ Cardiovasc Imaging 2014;8(1). doi: 10.1161/CIRCIMAGING.114.001998.
22. Masci PG, Schuurman R, Andrea B et al. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: A contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 2013;6:790–799.
23. Carasso S, Agmon Y, Roguin A et al. Left ventricular function and functional recovery early and late after myocardial infarction: A prospective pilot study comparing twodimensional strain, conventional echocardiography, and radionuclide myocardial perfusion imaging. J Am Soc Echocardiogr 2013;26(11): 1235–1244.
24. Lionetti V, Matteucci M, Ribezzo M et al. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy. J Cell Mol Med 2014;18:396–414.
25. Beeres SL, Lamb HJ, Roes SD et al. Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia. J Magn Reson Imaging 2008;27(5):992–997.